Part Details | DOPAMINE HYDROCHLORIDE INJECTION
6505-01-169-9573
Alternate Parts: NDC00186101213, NDC00186-1012-13, NDC00641011425, NDC00641-0114-25, 13405, NDC00469134020, NDC00469-1340-20, NDC39769001005, NDC39769-0010-05, 6505-01-169-9573, 01-169-9573, 6505011699573, 011699573
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JAN 18, 1984 | 01-169-9573 | 41749 ( DOPAMINE HYDROCHLORIDE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-169-9573
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00186-1012-13 | 04473 | ASTRA PHARMACEUTICALS LP |
| NDC00641-0114-25 | 51968 | ELKINS-SINN INC |
| 13405 | 60567 | LYPHOMED INCDIV OF FUJISAWA USA INC |
| NDC00469-1340-20 | 60567 | LYPHOMED INCDIV OF FUJISAWA USA INC |
| NDC39769-0010-05 | 60121 | SOLOPAK MEDICAL PRODUCTS INC |
Technical Data | NSN 6505-01-169-9573
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY80.000 MILLIGRAMS DOPAMINE |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| FEATURES PROVIDED | STERILE |
| SPECIAL FEATURES | NONPYROGENIC; TO BE DILUTED FOR INTRAVENOUS USE |